Newsfeeds Archive - Page 2 of 17

3 minute read

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday

May 8, 11:11 AM

U.S. stocks were mixed, with the Dow Jones gaining around 70 points on Wednesday. Shares of Louisiana-Pacific Corporation…

AMRC

3 minute read

Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High

By Shanthi Rexaline

May 8, 7:13 AM

U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Reserve officials.

ABNB

2 minute read

Investor Sentiment Falls Further, Dow Gains For Fifth Session

By Avi Kapoor

May 8, 3:49 AM

The CNN Money Fear and Greed index showed further decline in the overall market sentiment, while the index…

DIS

2 minute read

Uber, Lyft And 3 Stocks To Watch Heading Into Wednesday

By Avi Kapoor

May 8, 3:31 AM

With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor…

EMR

3 minute read

Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report

By Shanthi Rexaline

May 6, 5:25 AM

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

AAPL

2 minute read

Federal Trade Commission Targets ‘Junk Patent Listings’ For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca

By Vandana Singh

May 1, 4:11 PM

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic competition.

AMPH

2 minute read

US Supreme Court Declines To Hear Vanda Pharmaceuticals’ Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz

By Vandana Singh

April 22, 2:37 PM

"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact."

TEVA

2 minute read

‘The U.S Supreme Court Has Reportedly Declined To Hear Vanda Pharmaceuticals’ Case Regarding The Invalidation Of Certain Patents For Its Sleep-Wake Disorder Drug Hetlioz, That Were Previously Declared Invalid In A Dispute With Generic Drugmakers Teva A…

By Benzinga Newsdesk

April 22, 12:05 PM

https://finance.yahoo.com/news/1-u-supreme-court-rejects-153720025.htmlThe U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were

TEVA

2 minute read

Teva’s New Real-World Evidence Presented At The 2024 AAN Annual Meeting Confirms Effectiveness And Patient Satisfaction For HD Chorea With The 4-week Titration Kit For AUSTEDO Tablets

By Benzinga Newsdesk

April 16, 8:18 AM

Almost 80% of patients with Huntington's disease (HD) chorea were able to achieve optimal dosing within four weeks with the 4-week Titration Kit in final START study resultsSTART study results further support real-world

TEVA

1 minute read

Legal
News

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals Alleging Infringement Of US Patent Numbers 9,040,074 And 9,950,069

By Benzinga Newsdesk

April 3, 8:26 AM

UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a lawsuit in the U.S.

TEVA